Trans-well assay revealed that decreased EGFR expression could partially inhibit the increased migration caused by AVL9 overexpression in DLD1 cell, indicating that AVL9 promotes CRC cells migration via regulating EGFR expression (Fig. 5A). This evidence concerns the gene AVL9 and colorectal carcinoma.